144 Result(s)

Article

Sequential vs myeloablative vs reduced intensity conditioning for patients with myelodysplastic syndromes with an excess of blasts at time of allogeneic haematopoietic cell transplantation: a retrospective study by the chronic malignancies working party of the EBMT

The optimal conditioning for patients with higher risk MDS receiving potentially curative allogeneic haematopoietic stem cell transplant(allo-HCT) remains to be defined. This is particularly the case for patie...

V. Potter, L. Gras, L. Koster, N. Kroger, K. Sockel… in Bone Marrow Transplantation (2024)

Article

Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT

Systemic anaplastic large cell lymphoma (sALCL) is a rare histological entity expressing the CD30 antigen that comprises around 11% of peripheral T-cell lymphoma. We analysed the outcome of patients with relap...

E. Domingo-Domènech, A. Boumendil, F. Climent, H. Sengeloev… in Bone Marrow Transplantation (2020)

Article

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)

Preliminary data suggest that allogeneic stem cell transplantation (allo-SCT) may be effective in T-prolymphocytic leukemia (T-PLL). The purpose of the present observational study was to assess the outcome of ...

W. Wiktor-Jedrzejczak, J. Drozd-Sokolowska, D. J. Eikema… in Bone Marrow Transplantation (2019)

Article

High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group

To investigate safety and efficacy of high-dose chemotherapy followed by autologous stem cell transplantation (HCT-ASCT) in relapsed/refractory (r/r) primary central nervous system lymphoma (PCNSL), we conduct...

B Kasenda, G Ihorst, R Schroers, A Korfel, I Schmidt-Wolf, G Egerer… in Leukemia (2017)

Article

MicroRNA-146a reduces MHC-II expression via targeting JAK/STAT signaling in dendritic cells after stem cell transplantation

Acute Graft-versus-host disease (GVHD) is a major immunological complication after allogeneic hematopoietic cell transplantation and a better understanding of the molecular regulation of the disease could help...

N Stickel, K Hanke, D Marschner, G Prinz, M Köhler, W Melchinger, D Pfeifer… in Leukemia (2017)

Article

Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes

This study shows the long-term updated outcomes of a multicenter retrospective study which analyzed 843 patients with myelodysplastic syndrome (MDS) who underwent transplantation with an HLA-identical sibling ...

R Martino, A Henseler, M van Lint, N Schaap, J Finke… in Bone Marrow Transplantation (2017)

Article

Partial break in tolerance of NKG2A⁻/LIR-1⁻ single KIR⁺ NK cells early in the course of HLA-matched, KIR-mismatched hematopoietic cell transplantation

Natural killer (NK) cell subpopulations from 8 HLA-matched but killer cell immunoglobulin-like receptor (KIR)/HLA-ligand-mismatched patient–donor pairs were analyzed in the course of allogeneic hematopoietic s...

S Rathmann, C Keck, C Kreutz, N Weit, M Müller, J Timmer… in Bone Marrow Transplantation (2017)

Article

Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience

J Meissner, H Finel, S Dietrich, A Boumendil, E Kanfer… in Bone Marrow Transplantation (2017)

Article

Risk factors for treatment failure after allogeneic transplantation of patients with CLL: a report from the European Society for Blood and Marrow Transplantation

For young patients with high-risk CLL, BTK-/PI3K-inhibitors or allogeneic stem cell transplantation (alloHCT) are considered. Patients with a low risk of non-relapse mortality (NRM) but a high risk of failure ...

J Schetelig, L C de Wreede, M van Gelder, N S Andersen… in Bone Marrow Transplantation (2017)

Article

Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation

Even with the availability of targeted drugs, allogeneic hematopoietic cell transplantation (allo-HCT) is the only therapy with curative potential for patients with CLL. Cure can be assessed by comparing long-...

M van Gelder, L C de Wreede, M Bornhäuser, D Niederwieser… in Bone Marrow Transplantation (2017)

Article

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

We report a retrospective analysis of 246 myelodysplastic syndrome (MDS) patients in the EBMT (The European Society for Blood and Marrow Transplantation) database who were transplanted for International Progno...

M Robin, R Porcher, W Zinke-Cerwenka, A van Biezen, L Volin… in Bone Marrow Transplantation (2017)

Article

Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMT

This study evaluated the safety and efficacy of thiotepa-based regimens before allogeneic stem cell transplantation in 310 adult patients with AML. Disease status at the time of transplantation was CR1 in 50%,...

S Eder, M Labopin, J Finke, D Bunjes, A Olivieri… in Bone Marrow Transplantation (2017)

Article

Allogeneic hematopoietic cell transplantation with double alkylating agents containing reduced-intensity conditioning for patients ⩾60 years with advanced AML/MDS

H Bertz, M Lübbert, K Ohneberg, R Zeiser, R Wäsch, R Marks, J Finke in Leukemia (2016)

Article

Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party

We describe the use and outcomes of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for multiple myeloma (MM) in Europe between January 1990 and December 2012. We identified 7333 patients, media...

M Sobh, M Michallet, G Gahrton, S Iacobelli, A van Biezen, S Schönland… in Leukemia (2016)